Does carotid intima-media thickness regression predict reduction of cardiovascular events?

A meta-analysis of 41 randomized trials

Pierluigi Costanzo, Pasquale Perrone-Filardi, Enrico Vassallo, Stefania Paolillo, Paolo Cesarano, Gregorio Brevetti, Massimo Chiariello

Research output: Contribution to journalArticle

153 Citations (Scopus)

Abstract

Objectives The purpose of this study was to verify whether intima-media thickness (IMT) regression is associated with reduced incidence of cardiovascular events. Background Carotid IMT increase is associated with a raised risk of coronary heart disease (CHD) and cerebrovascular (CBV) events. However, it is undetermined whether favorable changes of IMT reflect prognostic benefits. Methods The MEDLINE database and the Cochrane Database were searched for articles published until August 2009. All randomized trials assessing carotid IMT at baseline, at end of follow-up, and reporting clinical end points were included. A weighted random-effects meta-regression analysis was performed to test the relationship between mean and maximum IMT changes and outcomes. The influence of baseline patients' characteristics, cardiovascular risk profile, IMT at baseline, follow-up, and quality of the trials was also explored. Overall estimates of effect were calculated with a fixed-effects model, random-effects model, or Peto method. Results Forty-one trials enrolling 18,307 participants were included. Despite significant reduction in CHD, CBV events, and all-cause death induced by active treatments (for CHD events, odds ratio [OR]: 0.82, 95% confidence interval [CI]: 0.69 to 0.96, p = 0.02; for CBV events, OR: 0.71, 95% CI: 0.51 to 1.00, p = 0.05; and for all-cause death, OR: 0.71, 95% CI: 0.53 to 0.96, p = 0.03), there was no significant relationship between IMT regression and CHD events (Tau 0.91, p = 0.37), CBV events (Tau -0.32, p = 0.75), and all-cause death (Tau -0.41, p = 0.69). In addition, subjects' baseline characteristics, cardiovascular risk profile, IMT at baseline, follow-up, and quality of the trials did not significantly influence the association between IMT changes and clinical outcomes. Conclusions Regression or slowed progression of carotid IMT, induced by cardiovascular drug therapies, do not reflect reduction in cardiovascular events.

Original languageEnglish
Pages (from-to)2006-2020
Number of pages15
JournalJournal of the American College of Cardiology
Volume56
Issue number24
DOIs
Publication statusPublished - Dec 7 2010

Fingerprint

Carotid Intima-Media Thickness
Coronary Disease
Meta-Analysis
Cause of Death
Odds Ratio
Confidence Intervals
Databases
Cardiovascular Agents
MEDLINE
Regression Analysis
Drug Therapy
Incidence
Therapeutics

Keywords

  • Atherosclerosis
  • Cardiovascular risk
  • Intima-media thickness

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Does carotid intima-media thickness regression predict reduction of cardiovascular events? A meta-analysis of 41 randomized trials. / Costanzo, Pierluigi; Perrone-Filardi, Pasquale; Vassallo, Enrico; Paolillo, Stefania; Cesarano, Paolo; Brevetti, Gregorio; Chiariello, Massimo.

In: Journal of the American College of Cardiology, Vol. 56, No. 24, 07.12.2010, p. 2006-2020.

Research output: Contribution to journalArticle

Costanzo, Pierluigi ; Perrone-Filardi, Pasquale ; Vassallo, Enrico ; Paolillo, Stefania ; Cesarano, Paolo ; Brevetti, Gregorio ; Chiariello, Massimo. / Does carotid intima-media thickness regression predict reduction of cardiovascular events? A meta-analysis of 41 randomized trials. In: Journal of the American College of Cardiology. 2010 ; Vol. 56, No. 24. pp. 2006-2020.
@article{37441b051493450097003d1fde72e46d,
title = "Does carotid intima-media thickness regression predict reduction of cardiovascular events?: A meta-analysis of 41 randomized trials",
abstract = "Objectives The purpose of this study was to verify whether intima-media thickness (IMT) regression is associated with reduced incidence of cardiovascular events. Background Carotid IMT increase is associated with a raised risk of coronary heart disease (CHD) and cerebrovascular (CBV) events. However, it is undetermined whether favorable changes of IMT reflect prognostic benefits. Methods The MEDLINE database and the Cochrane Database were searched for articles published until August 2009. All randomized trials assessing carotid IMT at baseline, at end of follow-up, and reporting clinical end points were included. A weighted random-effects meta-regression analysis was performed to test the relationship between mean and maximum IMT changes and outcomes. The influence of baseline patients' characteristics, cardiovascular risk profile, IMT at baseline, follow-up, and quality of the trials was also explored. Overall estimates of effect were calculated with a fixed-effects model, random-effects model, or Peto method. Results Forty-one trials enrolling 18,307 participants were included. Despite significant reduction in CHD, CBV events, and all-cause death induced by active treatments (for CHD events, odds ratio [OR]: 0.82, 95{\%} confidence interval [CI]: 0.69 to 0.96, p = 0.02; for CBV events, OR: 0.71, 95{\%} CI: 0.51 to 1.00, p = 0.05; and for all-cause death, OR: 0.71, 95{\%} CI: 0.53 to 0.96, p = 0.03), there was no significant relationship between IMT regression and CHD events (Tau 0.91, p = 0.37), CBV events (Tau -0.32, p = 0.75), and all-cause death (Tau -0.41, p = 0.69). In addition, subjects' baseline characteristics, cardiovascular risk profile, IMT at baseline, follow-up, and quality of the trials did not significantly influence the association between IMT changes and clinical outcomes. Conclusions Regression or slowed progression of carotid IMT, induced by cardiovascular drug therapies, do not reflect reduction in cardiovascular events.",
keywords = "Atherosclerosis, Cardiovascular risk, Intima-media thickness",
author = "Pierluigi Costanzo and Pasquale Perrone-Filardi and Enrico Vassallo and Stefania Paolillo and Paolo Cesarano and Gregorio Brevetti and Massimo Chiariello",
year = "2010",
month = "12",
day = "7",
doi = "10.1016/j.jacc.2010.05.059",
language = "English",
volume = "56",
pages = "2006--2020",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "24",

}

TY - JOUR

T1 - Does carotid intima-media thickness regression predict reduction of cardiovascular events?

T2 - A meta-analysis of 41 randomized trials

AU - Costanzo, Pierluigi

AU - Perrone-Filardi, Pasquale

AU - Vassallo, Enrico

AU - Paolillo, Stefania

AU - Cesarano, Paolo

AU - Brevetti, Gregorio

AU - Chiariello, Massimo

PY - 2010/12/7

Y1 - 2010/12/7

N2 - Objectives The purpose of this study was to verify whether intima-media thickness (IMT) regression is associated with reduced incidence of cardiovascular events. Background Carotid IMT increase is associated with a raised risk of coronary heart disease (CHD) and cerebrovascular (CBV) events. However, it is undetermined whether favorable changes of IMT reflect prognostic benefits. Methods The MEDLINE database and the Cochrane Database were searched for articles published until August 2009. All randomized trials assessing carotid IMT at baseline, at end of follow-up, and reporting clinical end points were included. A weighted random-effects meta-regression analysis was performed to test the relationship between mean and maximum IMT changes and outcomes. The influence of baseline patients' characteristics, cardiovascular risk profile, IMT at baseline, follow-up, and quality of the trials was also explored. Overall estimates of effect were calculated with a fixed-effects model, random-effects model, or Peto method. Results Forty-one trials enrolling 18,307 participants were included. Despite significant reduction in CHD, CBV events, and all-cause death induced by active treatments (for CHD events, odds ratio [OR]: 0.82, 95% confidence interval [CI]: 0.69 to 0.96, p = 0.02; for CBV events, OR: 0.71, 95% CI: 0.51 to 1.00, p = 0.05; and for all-cause death, OR: 0.71, 95% CI: 0.53 to 0.96, p = 0.03), there was no significant relationship between IMT regression and CHD events (Tau 0.91, p = 0.37), CBV events (Tau -0.32, p = 0.75), and all-cause death (Tau -0.41, p = 0.69). In addition, subjects' baseline characteristics, cardiovascular risk profile, IMT at baseline, follow-up, and quality of the trials did not significantly influence the association between IMT changes and clinical outcomes. Conclusions Regression or slowed progression of carotid IMT, induced by cardiovascular drug therapies, do not reflect reduction in cardiovascular events.

AB - Objectives The purpose of this study was to verify whether intima-media thickness (IMT) regression is associated with reduced incidence of cardiovascular events. Background Carotid IMT increase is associated with a raised risk of coronary heart disease (CHD) and cerebrovascular (CBV) events. However, it is undetermined whether favorable changes of IMT reflect prognostic benefits. Methods The MEDLINE database and the Cochrane Database were searched for articles published until August 2009. All randomized trials assessing carotid IMT at baseline, at end of follow-up, and reporting clinical end points were included. A weighted random-effects meta-regression analysis was performed to test the relationship between mean and maximum IMT changes and outcomes. The influence of baseline patients' characteristics, cardiovascular risk profile, IMT at baseline, follow-up, and quality of the trials was also explored. Overall estimates of effect were calculated with a fixed-effects model, random-effects model, or Peto method. Results Forty-one trials enrolling 18,307 participants were included. Despite significant reduction in CHD, CBV events, and all-cause death induced by active treatments (for CHD events, odds ratio [OR]: 0.82, 95% confidence interval [CI]: 0.69 to 0.96, p = 0.02; for CBV events, OR: 0.71, 95% CI: 0.51 to 1.00, p = 0.05; and for all-cause death, OR: 0.71, 95% CI: 0.53 to 0.96, p = 0.03), there was no significant relationship between IMT regression and CHD events (Tau 0.91, p = 0.37), CBV events (Tau -0.32, p = 0.75), and all-cause death (Tau -0.41, p = 0.69). In addition, subjects' baseline characteristics, cardiovascular risk profile, IMT at baseline, follow-up, and quality of the trials did not significantly influence the association between IMT changes and clinical outcomes. Conclusions Regression or slowed progression of carotid IMT, induced by cardiovascular drug therapies, do not reflect reduction in cardiovascular events.

KW - Atherosclerosis

KW - Cardiovascular risk

KW - Intima-media thickness

UR - http://www.scopus.com/inward/record.url?scp=78649717560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78649717560&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2010.05.059

DO - 10.1016/j.jacc.2010.05.059

M3 - Article

VL - 56

SP - 2006

EP - 2020

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 24

ER -